LCN2 and psoriasis: IL-36 acts synergistically with TLRs to induce the expression of antimicrobial proteins (AMPs), such as cathelicidin (LL37) and lipocalin2 (LCN2), which is a potent neutrophil chemoattractant and participates in psoriasis [20].